SG/CALL/GILEAD SCIENCES/90/0.1/20.06.25 | Market Closed - Bid/Ask 03:45:58 2024-05-17 pm EDT | ||
| 0.14 EUR | -6.67% |
|
| Current month | +15.38% | ||
| 1 month | -21.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GILEAD SCIENCES, INC.
Latest news about GILEAD SCIENCES, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.14 | -6.67% |
| 24-05-16 | 0.15 | 0.00% |
| 24-05-15 | 0.15 | -6.25% |
| 24-05-14 | 0.16 | 0.00% |
| 24-05-13 | 0.16 | +14.29% |
Real-time Boerse Frankfurt Warrants
Last update May 17, 2024 at 03:45 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | GILEAD SCIENCES, INC. |
| Issuer | 
Société Générale
|
| WKN | SU2YPP |
| ISIN | DE000SU2YPP5 |
| Date issued | 2023-11-29 |
| Strike | 90 $ |
| Maturity | 2025-06-20 (399 Days) |
| Parity | 10 : 1 |
| Emission price | 0.41 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.97 € |
|---|---|
| Lowest since issue | 0.11 € |
| Spread | 0.01 € |
| Spread % | 6.67% |
Company Profile
Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows:
- sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV);
- other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products.
Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
Consensus: Gilead Sciences, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
67.86
USD
Average target price
82.93
USD
Spread / Average Target
+22.21%
- Stock Market
- Warrants
- Warrant